| scholarly article | Q13442814 |
| P2093 | author name string | Yu Fan | |
| Jun-Hua Zheng | |||
| Ming-Yue Tan | |||
| Sheng-Qiang Xia | |||
| P2860 | cites work | Rapamycin in transplantation: a review of the evidence | Q31789323 |
| The potential role of rapamycin in pediatric transplantation as observed from adult studies | Q33732940 | ||
| Sirolimus and mycophenolate mofetil for calcineurin-free immunosuppression in renal transplant recipients | Q34389093 | ||
| Safety and efficacy of TOR inhibitors in pediatric renal transplant recipients | Q34389100 | ||
| Sirolimus: a comprehensive review | Q34515537 | ||
| Strategies to improve long-term outcomes after renal transplantation | Q34539775 | ||
| Pathogenesis of chronic allograft rejection | Q35094243 | ||
| Rapid conversion to sirolimus for chronic progressive deterioration of the renal function in kidney allograft recipients | Q44491034 | ||
| Dyslipidemia in renal transplant recipients treated with a sirolimus and cyclosporine-based immunosuppressive regimen: incidence, risk factors, progression, and prognosis | Q44527275 | ||
| Differential effects of modern immunosuppressive agents on the development of intimal hyperplasia | Q44613352 | ||
| The natural history of chronic allograft nephropathy | Q44688416 | ||
| Sirolimus-based therapy following early cyclosporine withdrawal provides significantly improved renal histology and function at 3 years | Q44899016 | ||
| Predictors of success in conversion from calcineurin inhibitor to sirolimus in chronic allograft dysfunction | Q45057604 | ||
| Sirolimus for solid organ transplantation in children | Q46504337 | ||
| Observation of efficacy and safety of converting the calcineurin inhibitor to sirolimus in renal transplant recipients with chronic allograft nephropathy | Q46511556 | ||
| Rapamune® (RAPA, rapamycin, sirolimus): mechanism of action immunosuppressive effect results from blockade of signal transduction and inhibition of cell cycle progression | Q57362835 | ||
| Efficacy of sirolimus compared with azathioprine for reduction of acute renal allograft rejection: a randomised multicentre study | Q57943257 | ||
| Increase of proteinuria after conversion from calcineurin inhibitor to sirolimus-based treatment in kidney transplant patients with chronic allograft dysfunction | Q59507566 | ||
| Nephrotoxicity of immunosuppressive drugs: long-term consequences and challenges for the future | Q73453363 | ||
| Improved graft survival after renal transplantation in the United States, 1988 to 1996 | Q73502580 | ||
| Hyperlipidemia in renal transplant recipients treated with sirolimus (rapamycin) | Q74593343 | ||
| The UNOS Scientific Renal Transplant Registry--ten years of kidney transplants | Q77907429 | ||
| P433 | issue | 3 | |
| P921 | main subject | chronic allograft nephropathy | Q1088059 |
| P304 | page(s) | 3552-3558 | |
| P577 | publication date | 2015-03-15 | |
| P1433 | published in | International Journal of Clinical and Experimental Medicine | Q6051338 |
| P1476 | title | Five-year follow-up after conversion from calcineurin inhibitor to sirolimus-based treatment in kidney transplant patients with chronic allograft nephropathy | |
| P478 | volume | 8 |
| Q47119738 | HMGB1, TGF-β and NF-κB are associated with chronic allograft nephropathy | cites work | P2860 |
Search more.